The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...
Breast Cancer Index re-stratifies 21-gene assay risk groups for late distant recurrence and extended endocrine therapy benefit: Results from the BCI Registry Study. This is an ASCO Meeting Abstract ...
A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes ...
Genomic profiling of lung adenocarcinoma and squamous carcinoma in Indian patients: Implications for precision oncology. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results